Inventor · disambiguated record
Joerg Bussenius
Also filed as: BUSSENIUS JOERG
19 granted patents·4 pending applications·155 citations·filing 2003–2024
94Inventor score
Top patents by PatentIndex Score
23 records- 0196US7803839B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2006·Granted Sep 28, 2010·46 cites·68 claims
- 0294US7915250B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2010·Granted Mar 29, 2011·22 cites·26 claims
- 0391US8372851B2Pyrazolo pyrimidines as casein kinase II (CK2) modulatorsEXELIXIS INC·Filed 2006·Granted Feb 12, 2013·20 cites·12 claims
- 0491US8362002B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2011·Granted Jan 29, 2013·12 cites·63 claims
- 0589US2025100966A1Mek inhibitors and methods of their useEXELIXIS INC·Filed 2024·Application pending·0 cites
- 0686US7576074B2Receptor-type kinase modulators and methods of useRICE KENNETH D·Filed 2003·Granted Aug 18, 2009·21 cites·47 claims
- 0780US8658654B2Receptor-type kinase modulators and methods of useRICE KENNETH D·Filed 2009·Granted Feb 25, 2014·3 cites·5 claims
- 0878US8076338B2Kinase modulators and methods of useANAND NEEL K·Filed 2005·Granted Dec 13, 2011·7 cites·53 claims
- 0978US7846959B2Raf modulators and methods of useEXELIXIS INC·Filed 2005·Granted Dec 7, 2010·3 cites·21 claims
- 1076US7994172B2[1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseasesEXELIXIS INC·Filed 2005·Granted Aug 9, 2011·4 cites·22 claims
- 1174US11597699B2MEK inhibitors and methods of their useEXELIXIS INC·Filed 2020·Granted Mar 7, 2023·0 cites·1 claims
- 1273US8637499B2Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufactureAAY NAING·Filed 2010·Granted Jan 28, 2014·5 cites·23 claims
- 1373US8101625B2Pyrimidinones as Casein Kinase II (CK2) modulatorsRICE KENNETH D·Filed 2006·Granted Jan 24, 2012·2 cites·13 claims
- 1473US7872014B2Anaplastic lymphoma kinase modulators and methods of useEXELIXIS INC·Filed 2004·Granted Jan 18, 2011·7 cites·24 claims
- 1569US8012956B2Tropane compoundsEXELIXIS INC·Filed 2008·Granted Sep 6, 2011·1 cites·18 claims
- 1666US2019144382A1MEK Inhibitors and Methods of Their UseEXELIXIS INC·Filed 2018·Application pending·0 cites
- 1765US8648066B2Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufactureANAND NEEL KUMAR·Filed 2010·Granted Feb 11, 2014·2 cites·34 claims
- 1864US2014275527A1Azetidines as MEK Inhibitors for the Treatment of Proliferative DiseasesEXELIXIS INC·Filed 2013·Application pending·0 cites
- 1962US9359332B2Processes for the preparation of substituted quinazolinesSYMPHONY EVOLUTION INC·Filed 2013·Granted Jun 7, 2016·0 cites·12 claims
- 2060US10266518B2Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereofSYMPHONY EVOLUTION INC·Filed 2017·Granted Apr 23, 2019·0 cites·21 claims
- 2157US2017166523A9MEK Inhibitors And Methods Of Their UseEXELIXIS INC·Filed 2015·Application pending·0 cites
- 2254US9796704B2Substituted quinazolines as receptor-type kinase inhibitorsSYMPHONY EVOLUTION INC·Filed 2015·Granted Oct 24, 2017·0 cites·7 claims
- 2342US8697737B2Raf modulators and methods of useANAND NEEL KUMAR·Filed 2010·Granted Apr 15, 2014·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Joerg Bussenius files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →